Rotator Cuff Arthropathy
8
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Prosthesis Versus Active Exercise Program in Patients With Rotator Cuff Arthropathy
Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Shoulder Prosthesis System
RETRO-PROSPECTIVE POSTMARKET CLINICAL STUDY FOR FX SHOULDER SOLUTIONS SHOULDER SYSTEMS
Corticosteroid Injection Versus Nerve Block
Focus on the Humeral Component Following Reverse Shoulder Arthroplasty
Clinical Trial to Analyze Lateralized Models and Medializations of Inverted Arthroplasty.
Influenze of Approach in Reversed Shoulder Prosthesis
Reverse Shoulder Prosthesis Study